Innovation

The research outlines paths for future obesity solutions.

A novel surgical solution helps patients with urinary problems and pain due to radiation treatment.

Researchers reveal how a particular type of “jumping” gene came to make up 20 percent of human DNA.

A study reveals how BRCA2 determines which cancer cells respond to a major drug class.

Dr. Carlos Pinheiro Neto joins NYU Langone as vice chair of otolaryngology, bringing expertise in skull base surgery.

A partnership with God’s Love We Deliver ensures nutrition continues after hospital discharge.

A five-year study found that the procedure averted cancer recurrence.

Dr. Michael Dolinger will work at advancing care with innovative diagnostic techniques.

Its aim is to advance organ donation and establish it as a distinct clinical branch.

This moment ushers in new enthusiasm for the prospect of xenotransplanted organs in humans.